A Decade of Drug Policy a Civil Society Shadow Report - Executive Summary Taking Stock: a Decade of Drug Policy a Civil Society Shadow Report

Total Page:16

File Type:pdf, Size:1020Kb

A Decade of Drug Policy a Civil Society Shadow Report - Executive Summary Taking Stock: a Decade of Drug Policy a Civil Society Shadow Report TAKING STOCK: A DECADE OF DRUG POLICY A CIVIL SOCIETY SHADOW REPORT - EXECUTIVE SUMMARY TAKING STOCK: A DECADE OF DRUG POLICY A CIVIL SOCIETY SHADOW REPORT Taking stock: A decade of drug policy Funded by: Open Society Foundations Robert Carr Fund Partnership to Inspire, Transform and Connect the HIV response (PITCH) project Global Fund to Fight AIDS, Tuberculosis and Malaria Copy editing: Kay Bailey Graphics and design: Report design: Mathew Birch Cover design: Rudy Tun-Sánchez Figures and infographics: Juan Fernandez Ochoa, IDPC Printing: Printech Europe © International Drug Policy Consortium Publication 2018 Taking stock: A decade of drug policy Foreword on Drug Policy Global Commission Credit: Global drug control policies have been based on the general principles of eliminating the production, trade or use of any illegal psychoactive substance from the world. Yet policies which seek to reach that objective have involved harsh law-enforcement and even militarisation. These end up affecting the most vulnerable people who use drugs, subsistence farmers involved in illegal crop cultivation and small-scale traffickers because they are easier to apprehend than are wealthy and well-connected people. The collateral damages are human rights and lives – those of the most vulnerable and those of the voiceless. To quote the Deputy High Commissioner for Human Rights (May 2018), in a world that is meant to be more inclusive and where no one should be left behind, ‘people who use drugs Rt Hon Helen Clark are not left behind. They are left outside’. strategy for the next ten years. But how can we A decade ago, the international community plan the future without a serious and far-ranging reiterated its aspiration to achieve a drug-free assessment of the past’s errors and successes? How world. Yet over that decade, available data shows can we quantify the unintended consequences of that the production, sale, and consumption of currently illegal drugs are soaring. So are the harms drug control policies when they are not evaluat- related to current policies, with dramatic increases ed? Up until now, no comprehensive evaluation in overdoses, prison overcrowding, HIV and has been carried out either on progress towards hepatitis transmission, a more revenue-generating achieving the 2009 targets or on the consequences and increasingly violent illegal market, and in the of the past decade in global drug control on human condoning by some of extrajudicial killings against rights, health, security, development, the environ- people who use drugs – killings that often take ment, and on the lives of the millions of affected place in broad daylight. people worldwide. Ten years after the world’s governments adopted at Furthermore, there is little appetite among countries the UN the Political Declaration and Plan of Action for such a review from the UN, proving once more on drugs, there is still little discussion on how to that drug policy remains mostly an ideological evaluate the impact of current policies, or on how issue rather than a societal topic that needs to be to analyse the results of the policies implemented addressed based on evidence, dialogue, and building during this period. In 2014, there was a mid-term consensus. In that vacuum, I welcome this Civil High-Level Review of the Political Declaration and Society Shadow Report in which the International Plan of Action. It resulted in a new negotiated Drug Policy Consortium which provides us with an document that reiterated the commitments, without excellent overview of the progress and the lack of providing any such ‘High-Level Review’. Two years it made in the last decade, as well as highlighting later, the 2016 UNGASS on drugs provided another the challenges and opportunities ahead – using all opportunity to review the current approach, to no existing government-based and UN-based data, avail. Although progress was made in bringing in along with scientific and grey literature. more visibility to issues related to health, human rights and development, the resulting Outcome What we learn from the shadow report is compel- Document failed to recognise the harmful ling. Since governments started collecting data consequences of the war on drugs approach. on drugs in the 1990s – based on the seizures of illegal substances, on the arrests of people who The international community is meeting again at a use drugs and their admission to treatment ser- Ministerial Segment at the Commission on Narcot- vices, and on the eradication of illegal crops – the ic Drugs in March 2019 to decide upon a common cultivation, consumption and illegal trafficking of Taking stock: A decade of drug policy Taking stock: A decade of drug policy i drugs have reached record levels. Moreover, current has driven countries to agree on the paths to drug policies are a serious obstacle to other social control drugs is breaking, both at the multilateral and economic objectives: progress on combating and at the regional levels. the HIV epidemic had been significant in the last 20 years, but is now stalled among people who It is our hope, at the Global Commission on Drug inject drugs; prison overcrowding has worsened, Policy, that the next decade in global drug policy with a fifth of the world’s inmates being arrested will align with the 2030 Agenda for Sustainable for drug-related offences and mostly for drug use Development to alleviate the pain and suffering of alone; and the ‘war on drugs’ has resulted in mil- millions of people affected by current drug policies, lions of people murdered, disappeared, or internally with the objective of leaving no one behind. By displaced. As the situation stands today, the major providing the most comprehensive assessment Sustainable Development Goals that concern gen- of the past lost decade, I am certain that this Civil der equality, the protection of the environment, Society Shadow Report will greatly contribute to socioeconomic development, and the reduction of the global drug control debates and ensure that violence and corruption will not be achieved for an the coming decade will be better embedded in important part of the population because of current the international community’s priorities of human drug policies. rights, development, peace and security. But there is still hope for a better outcome and for the international community to do better during Rt Hon Helen Clark the 2019 high-level meeting. While the possibility Member of the Global Commission on Drug Policy of building a new negotiated political declaration Former Prime Minister of New Zealand, 1999-2008 and plan of action is unlikely with the lack of any monitoring and assessment apart from the current Former Administrator of the United Nations Devel- Shadow Report, the Vienna-based consensus that opment Programme, 2009-2017 ii Taking stock: A decade of drug policy Table of contents Foreword i Acknowledgements 5 Abbreviations 6 Executive summary 7 Part 1: Introduction 15 1 Background 16 1.1 The UNGASS decade: ‘A drug-free world, we can do it’ 16 1.2 The 10-year review of the 1998 Political Declaration 18 1.3 The 2009 Political Declaration and Plan of Action: Setting a new target date 18 1.4 The 2014 mid-term review of the 2009 Political Declaration: A missed opportunity 19 1.5 The 2016 UNGASS: The winds of change 20 1.6 The next step: The 2019 Ministerial Segment of the 62nd CND 22 2 Objective of this shadow report 23 3 Methodology 24 Part 2: Evaluating progress made in addressing the ‘world drug problem’ since the adoption of the 2009 Political Declaration and Plan of Action 25 1 Assessing progress made against Article 36 of the 2009 Political Declaration 26 1.1 The illicit cultivation of opium poppy, coca bush and cannabis plant 26 1.2 The illicit demand for narcotic drugs and psychotropic substances, and drug-related health and social risks 29 1.3 The illicit production, manufacture, marketing and distribution of, and trafficking in, psychotropic substances, including synthetic drugs 30 1.4 The diversion of and illicit trafficking in precursors 31 1.5 Money-laundering related to illicit drugs 32 2 Assessing progress made towards the 2009 Plan of Action against the broader priorities of the United Nations 34 2.1 Protecting human rights 34 2.1.1 The right to highest attainable standard of health 34 2.1.2 The right to enjoy the benefits of scientific research 55 2.1.3 The right to life 57 2.1.4 The right to be free from torture and other cruel, inhuman and degrading treatment or punishment 58 2.1.5 The right to liberty and to be free from arbitrary detention 63 2.1.6 The right to a fair trial and due process 66 2.1.7 The rights of indigenous peoples 66 2.1.8 The right to be free from discrimination 67 Taking stock: A decade of drug policy Taking stock: A decade of drug policy 1 2.2 Promoting peace and security 70 2.2.1 The ‘balloon effect’ and escalating levels of violence 70 2.2.2 The rise of crypto-drug markets 72 2.2.3 Tackling Money Laundering 75 2.3 Advancing development 78 2.3.1 Analysing factors leading to illegal cultivation 78 2.3.2 Promoting sustainable development in cultivation and trafficking areas 81 2.3.3 Support and cooperation for alternative development 83 2.3.4 Ensuring collaboration with local communities in illegal crop cultivation areas 84 2.3.5 Protecting the environment in drug control strategies 86 2.3.6 Ensuring that development assistance protects human rights 87 Part 3: What next: Designing new benchmarks for global drug policy 89 1 The UNGASS Outcome Document as a policy framework beyond 2019
Recommended publications
  • Download the Full Report
    H U M A N “They Treat Us Like Animals” R I G H T S Mistreatment of Drug Users and “Undesirables” in Cambodia’s WATCH Drug Detention Centers “They Treat Us Like Animals” Mistreatment of Drug Users and “Undesirables” in Cambodia’s Drug Detention Centers Copyright © 2013 Human Rights Watch All rights reserved. Printed in the United States of America ISBN: 978-1-62313-0817 Cover design by Rafael Jimenez Human Rights Watch is dedicated to protecting the human rights of people around the world. We stand with victims and activists to prevent discrimination, to uphold political freedom, to protect people from inhumane conduct in wartime, and to bring offenders to justice. We investigate and expose human rights violations and hold abusers accountable. We challenge governments and those who hold power to end abusive practices and respect international human rights law. We enlist the public and the international community to support the cause of human rights for all. Human Rights Watch is an international organization with staff in more than 40 countries, and offices in Amsterdam, Beirut, Berlin, Brussels, Chicago, Geneva, Goma, Johannesburg, London, Los Angeles, Moscow, Nairobi, New York, Paris, San Francisco, Tokyo, Toronto, Tunis, Washington DC, and Zurich. For more information, please visit our website: http://www.hrw.org DECEMBER 2013 978-1-62313-0817 “They Treat Us Like Animals” Mistreatment of Drug Users and “Undesirables” in Cambodia’s Drug Detention Centers Map 1: Closed Drug Detention Centers and the Planned National Center .............................. i Map 2: Current Drug Detention Centers in Cambodia .......................................................... ii Summary ........................................................................................................................... 1 Recommendations .............................................................................................................. 7 To the Government of Cambodia ..............................................................................................
    [Show full text]
  • TREATED with CRUELTY: ABUSES in the NAME of DRUG REHABILITATION Remedies
    TREATED WITH CRUELTY ABUSES IN THE NAME OF DRUG REHABILITATION Copyright © 2011 by the Open Society Foundations All rights reserved, including the right to reproduce this book or portions thereof in any form. For more information, contact: International Harm Reduction Development Program Open Society Foundations www.soros.org/harm-reduction Telephone: 1 212 548 0600 Fax: 1 212 548 4617 Email: [email protected] Cover photo: A heroin user stands in the doorway at the Los Tesoros Escondidos Drug Rehabilita- tion Center in Tijuana, Mexico. Addiction treatment facilities can be brutal and deadly places in Mexico, where better, evidence-based alternatives are rarely available or affordable. (Sandy Huf- faker/ Getty Images) Editing by Roxanne Saucier, Daniel Wolfe, Kathleen Kingsbury, and Paul Silva Design and Layout by: Andiron Studio Open Society Public Health Program The Open Society Public Health Program aims to build societies committed to inclusion, human rights, and justice, in which health-related laws, policies, and practices reflect these values and are based on evidence. The program works to advance the health and human rights of marginalized people by building the capacity of civil society leaders and organiza- tions, and by advocating for greater accountability and transparency in health policy and practice. International Harm Reduction Development Program The International Harm Reduction Development Program (IHRD), part of the Open Society Public Health Program, works to advance the health and human rights of people who use drugs. Through grantmaking, capacity building, and advocacy, IHRD works to reduce HIV, fatal overdose and other drug-related harms; to decrease abuse by police and in places of detention; and to improve the quality of health services.
    [Show full text]
  • 1. CAMBODIA 1.1 General Situation 1.1.1 Drug Use There Are No
    COUNCIL OF Brussels, 15 April 2014 THE EUROPEAN UNION (OR. en) 8990/14 CORDROGUE 26 ASIE 22 NOTE From: Japanese Regional Chair of the Dublin Group To: Dublin Group No. prev. doc.: 14715/13 Subject: Regional Report on South East Asia and China 1. CAMBODIA 1.1 General situation 1.1.1 Drug use There are no consistent statistics as to the exact number of people who use drugs in Cambodia. However the general consensus among the Royal Government of Cambodia and international agencies is that there are currently between 12,000 and 28,000 people who use drugs. Methamphetamine pills are the most widely used drug in Cambodia, although crystalline methamphetamine is becoming more widely available, with use on the rise, particularly in Phnom Penh and among unemployed youth. Whereas illicit drug use was previously concentrated primarily in urban settings, in recent years it has been expanding into rural areas, in particular in the provinces adjacent to Lao PDR and Thailand (INCSR Cambodia 2012). Drug use among women and within prisons appears to be on the rise (UNODC 2013). 8990/14 JV/fm 1 DG D 2C EN Table 1. Rank of primary drugs of concern in Cambodia, 2008-2012 Drug type 2008 2009 2010** 2011*** 2012**** Methamphetamine pills ● 2* 1 2 2 Crystalline methamphetamine ● 1* 2 1 1 Ecstasy ● ● ● 6 ● Cannabis ● ● 4 4 4 Heroin ● ● 3 5 ● Inhalants ● ● ● 3 3 Opium ● ● ● ● ● ● = Not reported Source(s): *NACD 2010a. **2010 rankings based on DAINAP data and Cambodia country reports. ***NACD 2012b. ****2012 rankings are based on data provided by the National Authority for Combating Drugs.
    [Show full text]
  • Report of the International Narcotics Control Board for 2015 (E/INCB/2015/1) Is Supple- Mented by the Following Reports
    INTERNATIONAL NARCOTICS CONTROL BOARD REPORT REPORT 2015 INTERNATIONAL NARCOTICS CONTROL BOARD CONTROL NARCOTICS INTERNATIONAL Report 2015 EMBARGO Observe release date: Not to be published or broadcast before Wednesday, 2 March 2016, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board in 2015 TheReport of the International Narcotics Control Board for 2015 (E/INCB/2015/1) is supple- mented by the following reports: Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes (E/INCB/2015/1/Supp.1) Narcotic Drugs: Estimated World Requirements for 2016—Statistics for 2014 (E/INCB/2015/2) Psychotropic Substances: Statistics for 2014—Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2015/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2015 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2015/4) The updated lists of substances under international control, comprising narcotic drugs, psychotropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E-1339 P.O.
    [Show full text]
  • UNODC, Synthetic Drugs in East and Southeast Asia
    Synthetic Drugs in East and Southeast Asia Latest developments and challenges May 2020 Global SMART Programme Copyright © 2020, United Nations Office on Drugs and Crime (UNODC). This publication may be reproduced in whole or in part and in any form for educational or non-profit purposes without special permission from the copyright holder, provided acknowledgement of the source is made. UNODC would appreciate receiving a copy of any publication that uses this publication as a source. Acknowledgements This report was prepared by the Global Synthetic Monitoring: Analyses, Reporting and Trends (SMART) Programme, Laboratory and Scientific Section with the support of the UNODC Regional Office for Southeast Asia and the Pacific. Supervision, direction and review Justice Tettey, Chief, Laboratory and Scientific Section Jeremy Douglas, Regional Representative, Southeast Asia and the Pacific Research and drafting Martin Raithelhuber, Illicit Synthetic Drugs Expert Tun Nay Soe, Inter-regional Programme Coordinator Inshik Sim, Drug Programme Analyst, Southeast Asia and the Pacific Joey Yang Yi Tan, Junior Professional Officer in Drug Research Graphic design and layout Akara Umapornsakula, Graphic Designer Administrative support Jatupat Buasipreeda, Programme Assistant The present report also benefited from the expertise and valuable contributions of UNODC colleagues in the Laboratory and Scientific Section and the Regional Office for Southeast Asia and the Pacific, including Tsegahiwot Abebe Belachew, Rebecca Miller, Reiner Pungs, and John Wojcik. Disclaimer This report has not been formally edited. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNODC or the Secretariat of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Assessment of Compulsory Treatment of People Who Use Drugs in Cambodia, China, Malaysia and Viet Nam: an Application of Selected Human Rights Principles
    Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: An application of selected human rights principles Western Pacific Region WHO Library Cataloguing in Publication Data Assessment of compulsary treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: an application of selected human rights principles. 1. Substance abuse, Intravenous - rehabilitation. 2. Substance abuse treatment centers. 3. Human rights. 4. HIV infections – transmission. ISBN 978 92 9061 417 3 (NLM Classification: WM 270) © World Health Organization 2009 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; e-mail: [email protected]).
    [Show full text]
  • Substance Abuses
    SUBSTANCE ABUSES THE HUMAN COST OF CAMBODIA’S ANTI-DRUG CAMPAIGN Amnesty International is a global movement of more than 7 million people who campaign for a world where human rights are enjoyed by all. Our vision is for every person to enjoy all the rights enshrined in the Universal Declaration of Human Rights and other international human rights standards. We are independent of any government, political ideology, economic interest or religion and are funded mainly by our membership and public donations. © Amnesty International 2020 Except where otherwise noted, content in this document is licensed under a Creative Commons Cover photo: This image shows the inside of a cell in Phnom Penh’s CC1 men’s facility at Prey Sar prison (attribution, non-commercial, no derivatives, international 4.0) licence. in April 2018. Prisoners are held in extremely cramped cells such as this, holding up to 530 people for up https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode to 24 hours per day. Prisoners are not provided any bedding, and cells are typically hot, humid, and For more information please visit the permissions page on our website: www.amnesty.org extremely uncomfortable. Diseases are rife. Photo supplied; photographer’s identity withheld. Where material is attributed to a copyright owner other than Amnesty International this material is not subject to the Creative Commons licence. First published in 2020 by Amnesty International Ltd Peter Benenson House, 1 Easton Street London WC1X 0DW, UK Index: ASA 23/2220/2020 Original language: English amnesty.org CONTENTS 1. EXECUTIVE SUMMARY 5 METHODOLOGY 9 2.
    [Show full text]
  • National Strategic Framework on Health and Drugs a Comprehensive Approach to Address Health, Social and Legal Consequences of Drug Use in Myanmar
    National Strategic Framework on Health and Drugs A Comprehensive Approach to Address Health, Social and Legal Consequences of Drug Use in Myanmar 2020 Contents FOREWORD 1 ACKNOWLEDGEMENTS 3 ACRONYMS 5 EXECUTIVE SUMMARY 7 INTRODUCTION 17 Rationale for the development of the National Strategic Framework on Health and Drugs 19 The scope of the NSF on Health and Drugs 20 Process for the development of the NSF 20 Geopolitical context of The Republic of the Union of Myanmar 21 Determinants of drug use 22 Overview of health, social and legal consequences of drug use 24 Prevalence and patterns of drug use in Myanmar 28 Overview of risk factors for HIV in Myanmar 29 Epidemiology of HIV, and coinfections with viral hepatitis and tuberculosis 31 Alignment of the NSF with international and regional resolutions and declarations 34 Alignment of the NSF with national policies, strategies and plans 36 Relevant sectors and ministries 39 STRATEGIC DIRECTION 1. PRIMARY PREVENTION OF DRUG USE 41 Definition and introduction 43 Effectiveness of prevention of drug use: global evidence 44 Prevention of drug use in Myanmar 46 Challenges and gaps in drug use prevention 49 RECOMMENDATIONS FOR THE STRATEGIC DIRECTION 1 51 STRATEGIC DIRECTION 2. HARM REDUCTION 57 Definition and introduction 59 Preventing injection drug use initiation 62 Addressing health consequences of drug use in Myanmar 63 Overview of the harm reduction response in Myanmar 64 Funding for HIV and harm reduction response 66 Implementation of the harm reduction response in Myanmar 67 Overview of the status of implementation of the comprehensive harm reduction package 68 Interventions aimed at preventing sexual transmission among PWID and their sexual partners 73 Harm reduction in prisons 75 Harm reduction in the context of ATS use 76 Drug use among women 78 Challenges and gaps in harm reduction 78 RECOMMENDATIONS FOR THE STRATEGIC DIRECTION 2 82 STRATEGIC DIRECTION 3.
    [Show full text]
  • Fire and Ice: Conflict and Drugs in Myanmar’S Shan State
    Fire and Ice: Conflict and Drugs in Myanmar’s Shan State Asia Report N°299 | 8 January 2019 Headquarters International Crisis Group Avenue Louise 149 • 1050 Brussels, Belgium Tel: +32 2 502 90 38 • Fax: +32 2 502 50 38 [email protected] Preventing War. Shaping Peace. Table of Contents Executive Summary ................................................................................................................... i I. Introduction ..................................................................................................................... 1 II. A Long Legacy ................................................................................................................... 3 III. A New Drug Dynamic ....................................................................................................... 6 A. A Surge in Production ................................................................................................ 6 B. Tip of the Iceberg ....................................................................................................... 10 IV. The Links Between Drugs and Conflict ............................................................................ 12 A. Current Conflict Dynamics ........................................................................................ 12 B. The Role of the Drug Trade in the Conflict................................................................ 13 C. Ethno-political Clashes, Anti-drug Raids or Bank Heists? ....................................... 15 D. Why Is There Not
    [Show full text]
  • Overview of Drug Situation in Asia: Emerging Concerns
    OVERVIEW OF DRUG SITUATION IN ASIA: EMERGING CONCERNS Methamphetamine is the main drug of concern in treatment in Asia. Since the latter part of the 2000s, there has been a strong shift in the drug market in East and South-East Asia, from opiates to methamphetamine; 13 countries in the region reported methamphetamine as their primary drug of concern in 2018 or the latest year available; Annual prevalence of methamphetamine use ranges between 0.5 and 1.1 per cent, which is rather high compared with the global average; 2 OVERVIEW OF DRUG SITUATION IN ASIA: EMERGING CONCERNS South-East Asia emerges as the world’s fastest-growing methamphetamine market; Quantities of methamphetamine seized in East and South-East Asia rose more than eightfold between 2007 and 2017 to 82 tons – 45 per cent of global seizures; In 2017, seizures of methamphetamine tablets in the region amounted to nearly 450 million tablets, a 40% increase compared to the preceding year; Preliminary data for 2018 indicate a further steep increase of seizure to roughly 116 tons; 3 OVERVIEW OF DRUG SITUATION IN ASIA: EMERGING CONCERNS Increased quantities of methamphetamine seizures and decreases in retail prices of the drug in East and South-East Asia suggest that the supply of the drug has expanded; Viet Nam authorities have reported a price of US $ 8,000 for 1 kg of crystalline methamphetamine perceived to have originated from the Golden Triangle in 2017, down from the US $ 13,500 reported in 2016; Transnational organized crime (TOC) groups operating in the region have been increasingly involved in the manufacture and trafficking of methamphetamine and other drugs in the Golden Triangle in recent years; 4 OVERVIEW OF DRUG SITUATION IN ASIA: EMERGING CONCERNS Methamphetamine related treatment admissions account for a large majority of all drug related treatment admissions in the region; This included countries such as Myanmar, who traditionally have a larger proportion of other drug related admissions, other than methamphetamine.
    [Show full text]
  • Pregnant Women and Drugs in Phnom Penh
    Advanced Medical Science – International Health (01518) “No need to spend time on them, they are useless” The specific needs, perceptions and vulnerabilities of and surrounding pregnant women who use drugs in Phnom Penh, Cambodia. Haylee Rae Walsh (314929) Supervised by Dr Nick Thomson May 2011 WALSH 314929 Abstract This study took place in Phnom Penh, Cambodia and explored the specific needs and perceptions and subsequently the vulnerabilities that pregnant women who use drugs experience in their day-to-day life. Women who use drugs make up 6.5% of all people who use drugs in Cambodia, and NGO Friends-International identified an increase in the number of pregnant women accessing their various programs and services. The study involved 18 participant interviews with women who use(d) drugs during their pregnancy and 21 interviews with key informants from various organisations in Cambodia, conducted in January and February 2011. Oral consent was obtained to preserve the identities of participants and KIs. Thematic analysis of transcripts identified that women who use drugs during pregnancy have needs associated with survival on the street, harm reduction, and reintegration into their community. In addition to these general needs, pregnant women who use drugs also have specific needs concerning their health and that of their unborn child. Stigma in the community and discrimination towards pregnant women who use drugs was also identified. Contributing factors to the vulnerability of women who use drugs during pregnancy were fear of or actual
    [Show full text]
  • “Skin on the Cable”
    H U HUMAN RIGHTS WATCH M HUMAN A th N 350 Fifth Avenue, 34 Floor R I New York, NY 10118-3299 G RIGHTS H T S W WATCH A www.hrw.org T C H | J a n u a r “Skin on the Cable” y 2 0 The Illegal Arrest, Arbitrary Detention and Torture of People Who Use Drugs in Cambodia 1 0 In Cambodia, “undesirable” people such as the homeless, beggars, street children and sex workers are often arrested and detained in government centers. “Skin on the Cable” documents the treatment of one such “undesirable” group—people who use drugs—by law enforcement officials and staff working at government drug detention centers. In 2009 there were 11 government detention centers claiming to provide drug “treatment” and “rehabilitation”. These centers hold people rounded up by police or arrested on the request- and payment- of family members. Their detention is without any judicial oversight. In 2008 over 2,300 people were detained in such centers, including many children under 15 and people with mental illnesses. The Cambodia government’s policy of compulsory drug “treatment” in detention centers is both ineffective and abusive. People are detained even if they are not dependent on drugs. The mainstays of "treatment" in such centers are arduous physical exercises and forced labor. Indeed, sweating while exercising or laboring appears to be the most common means to “cure” drug dependence. Compounding the therapeutic ineffectiveness of detention is the extreme cruelty experienced at the hands—and C boots, truncheons and electric batons—of staff in these centers.
    [Show full text]